Hayakawa Mikito, Yamagami Hiroshi, Matsumaru Yuji, Hirata Koji, Hosoo Hisayuki, Ito Yoshiro, Marushima Aiki, Tsuruta Wataro, Iihara Koji, Ishii Akira, Imamura Hirotoshi, Sakai Chiaki, Satow Tetsu, Yoshimura Shinichi, Sakai Nobuyuki
Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital, Tsukuba, Japan; Department of Neurology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital, Tsukuba, Japan; Department of Stroke Neurology, NHO Osaka National Hospital, Osaka, Japan.
J Stroke Cerebrovasc Dis. 2025 Jan;34(1):108110. doi: 10.1016/j.jstrokecerebrovasdis.2024.108110. Epub 2024 Nov 3.
This study aimed to examine nationwide trends in acute stroke endovascular thrombectomy (EVT) following five pivotal trials in 2015 that established it as the 'standard of care'.
The Japanese Registry of NeuroEndovascular Therapy 4 was a nationwide retrospective study registering consecutive patients who underwent neurointervention by specialists certified by the Japanese Society for Neuroendovascular Therapy at 166 centers from January 2015 to December 2019. We extracted patients who underwent EVT, and analyzed the annual trends in baseline characteristics, revascularization procedures and outcomes.
A total of 13,090 patients (75.3 ± 12.2 years, 5637 women) were included. Analyses revealed an annual increase in patient age and treatments beyond 6 h after onset. However, there was an annual decline in premorbidly independent patients and those with large vessel occlusion. The frequency of stent-aspiration techniques and rate of successful reperfusions significantly increased from 19.9 % to 51.0 % and from 81.4 % to 83.9 %, respectively through the study period. Trends in patients achieving a favorable (modified Rankin Scale score of 0-2 at 30 days) or fatal outcome, or experiencing intracranial hemorrhagic complications remained unchanged. However, calendar time was associated with favorable outcomes after adjusting for clinical and treatment characteristics (odds ratio, 1.040; P = 0.015).
During the study period, EVT indications expanded for patients with characteristics linked to worse outcomes. However, factors such as advancements in techniques, have led to modest but significant improvements in reperfusion status, leading to maintenance of the post-EVT clinical outcomes.
URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000038869.
本研究旨在探讨2015年五项关键试验确立急性卒中血管内血栓切除术(EVT)为“标准治疗方法”后,全国范围内该手术的发展趋势。
日本神经血管内治疗注册研究4是一项全国性回顾性研究,对2015年1月至2019年12月期间在166个中心接受日本神经血管内治疗学会认证专家进行神经介入治疗的连续患者进行登记。我们提取了接受EVT的患者,并分析了基线特征、血管再通程序和结局的年度趋势。
共纳入13090例患者(75.3±12.2岁,5637例女性)。分析显示患者年龄和发病后6小时以上的治疗每年都在增加。然而,病前独立患者和大血管闭塞患者的数量每年都在下降。在研究期间,支架取栓技术的频率和成功再灌注率分别从19.9%显著提高到51.0%,从81.4%提高到83.9%。达到良好结局(30天时改良Rankin量表评分为0-2)、致命结局或发生颅内出血并发症的患者趋势保持不变。然而,在调整临床和治疗特征后,日历时间与良好结局相关(优势比,1.040;P=0.015)。
在研究期间,EVT的适应症扩大到与较差结局相关的患者。然而,技术进步等因素已导致再灌注状态有适度但显著的改善,从而维持了EVT后的临床结局。